Cargando…
A Response Assessment Platform for Development and Validation of Imaging Biomarkers in Oncology
Quantitative imaging biomarkers are increasingly used in both oncology clinical trials and clinical practice aid evaluation of tumor response to novel therapies. To obtain these biomarkers, and to ensure smooth clinical adoption once they have been validated, it is critical to develop reliable compu...
Autores principales: | Yang, Hao, Schwartz, Lawrence H., Zhao, Binsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Grapho Publications, LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037929/ https://www.ncbi.nlm.nih.gov/pubmed/30042969 http://dx.doi.org/10.18383/j.tom.2016.00223 |
Ejemplares similares
-
A Web-Based Response-Assessment System for Development and Validation of Imaging Biomarkers in Oncology
por: Yang, Hao, et al.
Publicado: (2019) -
Imaging response assessment in oncology
por: Curran, S D, et al.
Publicado: (2006) -
Assessing Agreement between Radiomic Features Computed for Multiple CT Imaging Settings
por: Lu, Lin, et al.
Publicado: (2016) -
A Quantitative Multiparametric MRI Analysis Platform for Estimation of Robust Imaging Biomarkers in Clinical Oncology
por: LoCastro, Eve, et al.
Publicado: (2023) -
Toward radiomics for assessment of response to systemic therapies in lung cancer
por: Sun, Shawn, et al.
Publicado: (2020)